Market Place
Sourcing Support
Genflow Biosciences PLC Announces Holding(s) in Company - 2
13 Jan 2025 //
ACCESSWIRE
Genflow Biosciences PLC Announces 2024 Highlights
06 Jan 2025 //
ACCESSWIRE
Genflow Secures Non-Dilutive Financial Support
21 Oct 2024 //
ACCESSWIRE
Genflow Biosciences PLC Announces Strengthening of Pre-Clinical Efforts
27 Jun 2024 //
ACCESSWIRE
Genflow Biosciences Plc Announces Result of AGM
27 Jun 2024 //
ACCESSWIRE
Genflow Biosciences PLC Announces Notice of AGM
03 Jun 2024 //
ACCESSWIRE
Genflow Biosciences PLC Announces Receipt of Grant Funding
30 May 2024 //
ACCESSWIRE
Genflow Biosciences PLC Announces Holding(s) in Company
10 May 2024 //
ACCESSWIRE
Genflow Biosciences Announces Listing Restoration
08 May 2024 //
ACCESSWIRE
Genflow Biosciences PLC Announces Final Results
07 May 2024 //
ACCESSWIRE
Genflow Biosciences PLC Announces Temporary Suspension
01 May 2024 //
ACCESSWIRE
Genflow Biosciences PLC Announces Notification of Major Holdings
10 Apr 2024 //
ACCESSWIRE
Genflow Biosciences PLC Announces Notification of Major Holdings - 1
09 Apr 2024 //
ACCESSWIRE
Genflow Biosciences PLC Announces Publication of a Key European Patent
21 Mar 2024 //
ACCESSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.